Journals / Tüberküloz ve Toraks / 2005 / Cilt: 53 - Sayı: 2

Nadir görülen birliktelik: Castleman hastalığı ve pemfigus vulgaris

A rare association: Castleman’s disease and pemphigus vulgaris

Pages
172–176
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We have wanted to discuss a 28 years old female with the literature review since the association between pemphigus vulgaris and Castleman's disease is rare.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Castleman disease is a reactive lymph node hyperplasia of unknown origin that often involving the thorax although it may involve all parts of the body.
📊
Key Findings & Data:It is usually seen in young adults and presents an asymptomatic course.
💡
Conclusion & Impact:We have wanted to discuss a 28 years old female with the literature review since the association between pemphigus vulgaris and Castleman's disease is rare.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Castleman disease is a reactive lymph node hyperplasia of unknown origin that often involving the thorax although it may involve all parts of the body. It is usually seen in young adults and presents an asymptomatic course. It is usually located to anterior and middle mediastinum. Pemphigus vulgaris is a bullous skin disease in which immune mechanisms take place in the pathögenesis. Mouth and oropharynx are the most commonly involved structures. IgG antibodies against the epidermal intracellular structures are essential in the diagnosis. We have wanted to discuss a 28 years old female with the literature review since the association between pemphigus vulgaris and Castleman's disease is rare.

Özet

Castleman hastalığı, etyolojisi tam olarak aydınlatılmayan, tüm vücutta bulunabilmekle beraber sıklıkla toraksta yerleşen reaktif lenf nodu hiperplazisidir. Genellikle genç erişkinlerde görülür ve asemptomatik seyreder. Sıklıkla ön ve orta mediastende lokalizedir. Pemfigus vulgaris, patogenezinde immün mekanizmaların rol oynadığı büllöz bir deri hastalığıdır. En sık ağız ve orofarenks etkilenir. Epidermal intraselüler yapılara karşı gelişen IgG antikorların varlığı teşhiste gereklidir. Castleman hastalığı ile oral pemfigus vulgaris birlikteliğinin nadir olması nedeniyle, 28 yaşında kadın olguyu literatür eşliğinde tartışmak istedik.

🔖

Cite This Article

ZİNDANCI, İ., MİHMANLI, A., SELVİ, A., ERTUĞRUL, M., ÜSKÜL, B., TÜRKER, H. (2022). Nadir görülen birliktelik: Castleman hastalığı ve pemfigus vulgaris. Tüberküloz ve Toraks, Cilt: 53 - Sayı: 2, 172–176. https://ajindex.com/articles/619166

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Pietra GG, Salhany KE. Lymphoproliferative and hematologic diseases involving the lung. In: Fishman AP (ed).Fishman's Pulmonary Diseases and Disorders. New York: McGraw-Hill, 1998:1861-79
  2. Gill A, Ngan BY, Lester R. Castleman's disease associated with pemphigus vulgaris. J Am Acad Dermatol 1991; 25: 955-9
  3. Jegasothy BV. Pulmonary cutaneous disorders. In: Fishman AP (ed). Fishman's Pulmonary Diseases and Disorders.New York:McGraw-Hill,1998: 394-416
  4. Frizzera G. Castleman's disease and related disorders. Semin Diagn Pathol 1988; 5:346-64
  5. Ülman C, Akyer E, Türker H ve ark. Nadir görülen lenfnodu hastalığı: Castleman hastalığı. Solunum 2002; 4:255-8
  6. Goldberg MA, Deluca S. Castleman's disease. Am Fam Physician 1989; 40: 151-3
  7. Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001; 92: 670-6
  8. Day JR, Bew D, Ali M, et al. Castleman 's disease associated with myastenia gravis. Ann Thorac Surg 2003; 75:1648-50
  9. Larroche C, Cacoub P, Soulier J, et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 2002; 69:119-26
  10. Saif MW. Castleman disease in an HIV-infected patient with Kaposi sarcoma. AIDS Read 2001; 11: 572-6
  11. Chorzelski T, Hashimoto T, Maciejewska B, et al. Paraneoplastic pemphigus associated with Castleman tumor,myastenia gravis, and bronchiolitis obliterans. J Am Acad Dermatol 1999; 41: 393-400
  12. Aoki Y, Tosato G. Pathogenesis and manifestations of human herpesvirus-8 associated disorders. Semin Hematol 2003;40: 143-53
  13. Maloisel F, Anders E, Campos F, et al. Is there a place for interferon alpha treatment strategy of multicentric Castleman 's disease? Rev Med Interne 2000; 21: 435-8
  14. Nord JA, Karter D. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease. Int J STD AIDS 2003; 14: 61-2
  15. Meyer L, Gibbons D, Ashfaq R, et al. Fine-needle aspiration findings in Castleman's disease. Diagn Cytopathol 1999; 21:57-60
  16. Nousari HC, Anhalt GJ. Pemphigus and bullous pemphigoid. Lancet 1999; 354: 667-72
  17. Richard OB, William JD, Timoty BG. Chronic blistering dermatoses. Andrew's Diseases of the Skin: Clinical Dermatology. Philadelphia: WB Saunders, 2000:574-605
  18. Memişoğlu R, Uzun S. Immünobülloz dermatozlarda tedavi. Gürgey E (editör)
  19. Prof. Dr. A. Lütfü Tat Sempozyumu Kitabı. Ankara: Nurol Matbaacılık, 1997:99-116. 19.